|
|
 |
SENSEX
|
 |
-232.85
|
-0.95%
|
24363.30
|
|
|
NIFTY
|
 |
-765.47
|
-0.95%
|
79857.79
|
|
|
Nasdaq
|
 |
207.32
|
0.98%
|
21450.02
|
|
|
Nikkei 225
|
 |
761.33
|
1.85%
|
41820.48
|
|
|
FTSE 100
|
 |
-5.10
|
-0.06%
|
9095.70
|
|
|
 |
|
|
|
|
|
YOU ARE ON
Equity
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
BSE Code |
543245
|
ISIN Demat |
INE068V01023
|
Book Value (Rs) |
608.43
|
|
NSE Code |
GLAND
|
Dividend Yield % |
0.93
|
Market Cap (Rs) |
318474.17
|
|
TTM PE(x) |
28.03
|
TTM EPS(Rs) |
68.96
|
Face Value(Rs.) |
1
|
|
|
|
|
|
|
Incorporation Year
|
20-03 1978
|
Registered Office
|
Survey No. 143-148, 150 & 151, Near Gandimaisamma ‘x’ Roads,D. P. Pally, Dundigal, Dundigal-gandimaisamma Mandal,Medchal- Malkajgiri District, Hyderabad, Telangana-500043 .
|
ISINNO
|
INE068V01023
|
Phone
|
040 30510999
|
E-mail
|
gland@glandpharma.com / investor@glandpharma.com |
URL
|
www.glandpharma.com |
Industry
|
Pharmaceuticals & Drugs
|
Chairman
|
Srinivas Sadu
|
Managing Director
|
|
Company Secretary
|
Sampath Kumar Pallerlamudi
|
Listing
|
BSE,NSE
|
|
|
|
|
|
|
|
|
|
|
|